Effects on Immun System of Anesthesia
Investigation Of The Effects Of General Anesthesia On The Oxidant/Antioxidant System
1 other identifier
observational
45
1 country
1
Brief Summary
Introduction and Aim: Desflurane and sevoflurane are frequently used for maintenance of anesthesia and studies have shown that these anesthetics cause a variety of changes in oxidative stress and antioxidative defense mechanisms. The chemical structure of propofol is similar to some free radical consumers such as endogenous vitamin E and butylated hydroxene toluene. This study aims to compare the effects of sevoflurane, desflurane and propofol infusion anesthesia on the oxidant and antioxidant systems of patients undergoing laparoscopic cholecystectomy. Material and Method: Forty-five patients, ASA (American Society of Anesthesiologists) I-II, score between 18-50 years with planned laparoscopic cholecystectomy under general anesthesia were included in the study. Patients were divided into 3 groups as total intravenous anesthesia (TIVA) (group T n: 15), sevoflurane (group S n: 15) and desflurane (group D n: 15). Propofol 2 mg/kg IV, fentanyl 1 mcg/kg IV, vecuronium 0.1 mg/kg IV given to all groups for anesthesia induction. For maintenance of anesthesia group S were ventilated with 2% sevoflurane, 50% air and 50% O2 mix at 6 L/min flow. Group D were given 6% desflurane 50% air and 50% O2 mix at 6 L/min flow. Group T were given propofol infusions of 12 mg/kg/hr for the first 10 minutes, 9 mg/kg/hr for the second 10 minutes and 6 mg/kg/hr after that. Patients were ventilated with 50% air and 50% O2 mix at 6 L/min flow. Before induction and after the operation venous blood samples were taken to evaluate the levels of glutathion peroxidase, total oxidants and antioxidants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 29, 2014
CompletedFirst Posted
Study publicly available on registry
February 6, 2014
CompletedFebruary 6, 2014
February 1, 2014
6 months
January 29, 2014
February 5, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Levels of glutathion peroxidase, total oxidants and antioxidants.
Before induction and after the operation venous blood samples were taken to evaluate the levels of glutathion peroxidase, total oxidants and antioxidants.
24 hours
Study Arms (3)
TIVA (group T n: 15)
Group T were given propofol infusions of 12 mg/kg/hr for the first 10 minutes, 9 mg/kg/hr for the second 10 minutes and 6 mg/kg/hr after that. Patients were ventilated with 50% air and 50% O2 mix at 6 L/min flow.
Sevoflurane (group S n: 15)
Group S were ventilated with 2% sevoflurane, 50% air and 50% O2 mix at 6 L/min flow.
Desflurane (group D n: 15)
Group D cases were given 6% desflurane 50% air and 50% O2 mix at 6 L/min flow.
Eligibility Criteria
45 patients ASA I-II between 18-50 years with planned laparoscopic cholecystectomy under general anesthetic were included in the study. Patients were divided into 3 groups on the way to surgery; TIVA (group T n: 15), sevoflurane (group S n: 15) and desflurane (group D n: 15).
You may qualify if:
- ASA I-II with patients
- Between 18-50 years
- Planned laparoscopic cholecystectomy under general anesthetic
You may not qualify if:
- Patients with endocrine dysfunction
- blood transfusion in the previous 2 weeks
- signs of infection and inflammation
- history of preoperative medication use
- anemia
- hemorrhage requiring transfusion during the operation were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duzce Universitylead
Study Sites (1)
Duzce Univercity Medical Fauculty
Düzce, 81600, Turkey (Türkiye)
Biospecimen
Before induction and after the operation venous blood samples were taken.
Study Officials
- PRINCIPAL INVESTIGATOR
yavuz demiraran, MD prof
duzce university medical faculty
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Doctor
Study Record Dates
First Submitted
January 29, 2014
First Posted
February 6, 2014
Study Start
January 1, 2010
Primary Completion
July 1, 2010
Study Completion
January 1, 2011
Last Updated
February 6, 2014
Record last verified: 2014-02